ALNY logo Alnylam Pharmaceuticals : ALNY

ALNY

Stock Data

$296.11

Change down

$13.38 (4.32%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Alnylam Pharmaceuticals Inc is a pioneering biopharmaceutical firm dedicated to the development and commercialization of innovative therapeutics based on RNA interference. The company's portfolio includes treatments for rare genetic conditions, such as hereditary transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria type 1, among others. Alnylam is also exploring treatments for a variety of other diseases, including hemophilia, hypercholesterolemia, and Alzheimer’s disease. Founded in 2002 and headquartered in Cambridge, Massachusetts, Alnylam has formed strategic partnerships with several leading pharmaceutical companies to advance its mission of transforming scientific discoveries into breakthrough therapies.

All Alnylam Pharmaceuticals Articles

76 Articles

1 2 3 6

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.